Screener
Charles River Laboratories CRL United States
United States at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic.
The source filing: Charles River Laboratories’s 10-K, filed February 18, 2026.
- Filed
- Feb 18, 2026, 9:21 AM EST
- Fiscal year
- FY2025
- Accession
- 0001100682-26-000022
| Line item | Fiscal Year / 2025 | Fiscal Year / 2024 | Fiscal Year / 2023 |
|---|---|---|---|
| Income (loss) before income taxes: | |||
| U.S. | $(290,645) | $(290,308) | $185,667 |
| Non-U.S. | 191,142 | 383,422 | 395,617 |
| Total income (loss) before income taxes | $(99,503) | $93,114 | $581,284 |
| Income tax provision (benefit): | |||
| Current: | |||
| Federal | $10,872 | $36,349 | $49,090 |
| Foreign | 97,428 | 86,493 | 85,356 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Charles River Laboratories's united states?
- Charles River Laboratories (CRL) reported united states of -$72.66M in Q4 2025.
- How has Charles River Laboratories's united states changed year-over-year?
- Charles River Laboratories's united states decreased by 0.1% year-over-year, from -$72.58M to -$72.66M.
- What is the long-term trend for Charles River Laboratories's united states?
- Over 2 years (2023 to 2025), Charles River Laboratories's united states has grown at a 25.1% compound annual growth rate (CAGR), from $185.67M to -$290.65M.
- What does united states mean?
- United States as reported by Charles River Laboratories International, Inc..
Ask your AI about Charles River Laboratories's united states.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude